A. Oussalah, L. Evesque, and D. Laharie, A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy, and Hospitalization, The American Journal of Gastroenterology, vol.95, issue.12, pp.2617-2642, 2010.
DOI : 10.1016/j.cgh.2006.04.001

M. Arias, V. Casteele, N. Vermeire, and S. , A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis, Clinical Gastroenterology and Hepatology, vol.13, issue.3, pp.531-539, 2015.
DOI : 10.1016/j.cgh.2014.07.055

N. Gies, K. Kroeker, and K. Wong, Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort, Alimentary Pharmacology & Therapeutics, vol.137, issue.4, pp.522-530, 2010.
DOI : 10.1111/j.1365-2036.2010.04380.x

K. Lee, Y. Jeen, and J. Cho, Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: A Korean multicenter retrospective study, Journal of Gastroenterology and Hepatology, vol.57, issue.12
DOI : 10.1111/jgh.12324

C. Steenholdt, A. Molazahi, and M. Ainsworth, Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study, Scandinavian Journal of Gastroenterology, vol.138, issue.1, pp.518-545, 2012.
DOI : 10.1056/NEJMoa030815